1. Chotitumnavee J, Yamashita Y, Takahashi Y, Takada Y, Iida T, Oba M, Itoh Y, Suzuki T. Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC). Chemical Communications. 2022, 58, 4635-8, doi: 10.1039/d2cc00272h.
2. Itoh Y, Takada Y, Yamashita Y, Suzuki T. Recent progress on small molecules targeting epigenetic complexes. Current Opinion in Chemical Biology. 2022, 67, 102130, doi: 10.1016/j.cbpa.2022.102130.
3. Takada Y, Yamashita Y, Itoh Y, Suzuki T. Medicinal Chemistry Research on Targeting Epigenetic Complexes. Journal of Synthetic Organic Chemistry Japan. 2022, 80, 664-75, doi: 10.5059/yukigoseikyokaishi.80.664.
4. Zhe W, Hoshina N, Itoh Y, Tojo T, Suzuki T, Hase K, Takahashi D. A Novel HDAC1-Selective Inhibitor Attenuates Autoimmune Arthritis by Inhibiting Inflammatory Cytokine Production. Biological Pharmaceutical Bulletin. 2022, 45, 1364-72, doi: 10.1248/bpb.b22-00321.
5. Ota Y, Itoh Y, Kurohara T, Singh R, Elboray EE, Hu C, Zamani F, Mukherjee A, Takada Y, Yamashita Y, Morita M, Horinaka M, Sowa Y, Masuda M, Sakai T, Suzuki T. Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates. ACS Medicinal Chemistry Letters 2022, 13, 1568-1573, doi: 10.1021/acsmedchemlett.2c00126.
6. Fuentes, I., Morishita, Y., Gonzalez-Salinas, S., Champagne, AF., Uchida, S. Shumyatsky, GP. Experience-Regulated Neuronal Signaling in Maternal Behavior. Frontiers in Molecular Neuroscience 2022, 24, 844295, doi: 10.3389/fnmol.2022.844295.
7. Inaba H, Li H, Kawatake-Kuno A, Dewa KI, Nagai J, Oishi N, Murai T, Uchida S. GPCR-mediated calcium and cAMP signaling determines psychosocial stress susceptibility and resiliency. Science Advances 2023, 9:eade5397. doi: 10.1126/sciadv.ade5397.
8. Mishima H, Itoh Y, Kurohara T, Suzuki T, Asada N, Kusakabe K, Okamoto Y. Origin of the kinetic HDAC2-selectivity of an HDAC inhibitor. Journal of Computational Chemistry 2023, 44, in press, doi: 10.1002/jcc.27111.